NASDAQ · Financial Statements

Kezar Life Sciences (KZR) Financial Statements

$7.29 NASDAQ: KZR Market Cap $53.86M

Kezar Life Sciences most recently reported annual revenue of $0, a net loss of $56.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Kezar Life Sciences: net profit was positive in 0 of 10 reported years; the most recent year shows a net loss of $56.0M.

Income Statement — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Revenue$0$0$0$0$0$0$0$7.0M$0$0
Operating Expenses$9.0M$9.0M$25.0M$38.0M$43.0M$55.0M$71.0M$118.0M$91.0M$52.0M
Operating Profit$-9.0M$-9.0M$-25.0M$-38.0M$-43.0M$-55.0M$-71.0M$-111.0M$-91.0M$-52.0M
Operating Margin0.0%0.0%0.0%0.0%0.0%0.0%0.0%-1591.8%0.0%0.0%
Other Income$0$0$2.0M$2.0M$1.0M$0$3.0M$10.0M$7.0M$-4.0M
Interest$0$0$0$0$0$0$1.0M$2.0M$2.0M$0
Depreciation$0$0$1.0M$1.0M$2.0M$2.0M$1.0M$1.0M$1.0M$1.0M
Profit Before Tax$-9.0M$-9.0M$-23.0M$-36.0M$-42.0M$-55.0M$-68.0M$-102.0M$-84.0M$-56.0M
Tax$0$0$0$1.8M$140,000$0$0$0$0$0
Net Profit$-9.0M$-9.0M$-23.0M$-35.0M$-42.0M$-55.0M$-68.0M$-102.0M$-84.0M$-56.0M
EPS$-0.69$-0.65$-1.22$-1.65$-0.95$-1.04$-1.01$-1.40$-1.15$-7.66
Dividend Payout0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%

Quarterly Results — Last 12 Quarters (USD millions)

MetricMar '23Jun '23Sep '23Dec '23Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25
Revenue$0$0$7.0M$0$0$0$0$0$0$0$0$0
Operating Expenses$25.0M$27.0M$33.0M$28.0M$24.0M$23.0M$22.0M$22.0M$18.0M$15.0M$12.0M$8.0M
Operating Profit$-25.0M$-27.0M$-26.0M$-28.0M$-24.0M$-23.0M$-22.0M$-22.0M$-18.0M$-15.0M$-12.0M$-8.0M
Operating Margin0.0%0.0%-364.7%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Interest$0$0$0$0$0$0$0$0$0$0$0$0
Profit Before Tax$-22.0M$-24.0M$-23.0M$-32.0M$-22.0M$-22.0M$-20.0M$-20.0M$-17.0M$-14.0M$-11.0M$-15.0M
Tax$0$0$0$0$0$0$0$0$0$0$0$0
Net Profit$-22.0M$-24.0M$-23.0M$-32.0M$-22.0M$-22.0M$-20.0M$-20.0M$-17.0M$-14.0M$-11.0M$-15.0M
EPS$-0.28$-0.34$-0.32$-0.44$-0.30$-0.30$-0.28$-2.77$-2.27$-1.87$-1.53$-1.99

Over the 10 years reported for Kezar Life Sciences, cash stood at $72.0M in the latest year, shareholders' equity was $0, current assets covered current liabilities 10.86 times.

Balance Sheet — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Total Assets$11.0M$54.0M$115.0M$90.0M$152.0M$218.0M$300.0M$221.0M$145.0M$77.0M
Current Assets$10.0M$52.0M$110.0M$81.0M$145.0M$212.0M$286.0M$207.0M$137.0M$76.0M
Cash$10.0M$51.0M$24.0M$15.0M$21.0M$63.0M$40.0M$35.0M$42.0M$72.0M
Inventory$0$0$0$0$0$0$0$0$0$0
Receivables$0$0$0$1.0M$1.0M$0$0$2.0M$0$2.0M
Fixed Assets$1.0M$2.0M$5.0M$8.0M$7.0M$6.0M$13.0M$9.0M$5.0M$1.0M
Capital Work in Progress$0$0$0$0$0$0$0$0$0$0
Investments$0$0$83.0M$63.0M$119.0M$145.0M$236.0M$166.0M$90.0M$0
Other Assets$0$0$0$0$0$0$0$0$0$0
Total Liabilities$29.0M$80.0M$6.0M$11.0M$11.0M$21.0M$30.0M$34.0M$28.0M$7.0M
Current Liabilities$1.0M$1.0M$3.0M$6.0M$6.0M$8.0M$11.0M$18.0M$20.0M$7.0M
Borrowings$0$0$0$6.0M$5.0M$14.0M$21.0M$19.0M$16.0M$2.0M
Other Liabilities$29.0M$80.0M$6.0M$5.0M$5.0M$7.0M$8.0M$15.0M$12.0M$4.0M
Equity$0$0$0$0$0$0$0$0$0$0
Reserves$-17.0M$-26.0M$109.0M$78.0M$141.0M$197.0M$270.0M$188.0M$117.0M$70.0M

For Kezar Life Sciences, operating cash flow was positive in 0 of 10 reported years; free cash flow in the latest year was negative at $52.0M; free cash flow was positive in 0 of 10 years.

Cash Flow Statement — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Operating Cash Flow$-10.0M$-8.0M$-21.0M$-30.0M$-37.0M$-42.0M$-59.0M$-82.0M$-74.0M$-52.0M
Investing Cash Flow$0$-1.0M$-85.0M$20.0M$-57.0M$-29.0M$-93.0M$74.0M$80.0M$92.0M
Financing Cash Flow$0$0$0$0$0$2.0M$1.0M$0$0$0
Net Cash Flow$-10.0M$41.0M$-27.0M$-9.0M$6.0M$42.0M$-22.0M$-5.0M$6.0M$30.0M
Free Cash Flow$-10.0M$-8.0M$-22.0M$-30.0M$-37.0M$-43.0M$-60.0M$-83.0M$-74.0M$-52.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-96.24%
Quick Ratio10.86
Interest Coverage—
Return 1Y—
Return 3Y—
Return 5Y—

Kezar Life Sciences (KZR) financials — frequently asked questions

What is Kezar Life Sciences's annual revenue?

Kezar Life Sciences (KZR) reported annual revenue of $0 in its most recent fiscal year.

What is Kezar Life Sciences's net profit?

Kezar Life Sciences (KZR) reported a net loss of $56.0M in its most recent fiscal year.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens
KZR Overview KZR Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.